Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

How HIV works news

Show

From To
New research explains why HIV is not cleared by the immune system

Scientists have identified a human (host) protein that weakens the immune response to HIV and other viruses. The findings have important implications for improving HIV antiviral therapies, creating effective viral vaccines, and advance a new approach to treat cancer.

Published
15 April 2016
From
Science Daily
What Is Chronic Inflammation and Why Is It Such a Big Deal for People With HIV?

A primer on the harms of HIV-related chronic inflammation, what treatments are being researched and what you can do to reduce inflammation and improve your long-term health.

Published
06 April 2016
From
Poz
How HIV infection increases the risk of tuberculosis

A study published in PLOS Pathogens suggests that it is not a general weakening of the immune system by HIV that initially leads to loss of Mtb control, but rather that HIV is associated with a failure to prevent harmful immune responses. As HIV disease progresses, the weakening immune system's focus on antiviral responses leaves it largely defenseless against the Mtb pathogen.

Published
18 March 2016
From
HIV / AIDS News From Medical News Today
Bacteria, viruses in gut linked to severity of HIV infection

HIV infection also can lead to diseases affecting the intestines, with increased gastrointestinal (GI) inflammation, diarrhea and problems with nutrient absorption. The role of gut microbes in such issues is not completely understood, but now, in two studies led by researchers at Washington University School of Medicine in St. Louis, scientists have identified intestinal bacteria and viruses as possible sources of such inflammation and disease.

Published
11 March 2016
From
HIV / AIDS News From Medical News Today
Bacteria in our gut affects HIV—is there a solution?

Across our bodies colonies of microorganisms flourish. The largest microbiome colony lives in our gastrointestinal tract—our gut—and in healthy people, helps us do things like digest carbohydrates, produce vitamins and prevent harmful pathogens from flourishing. When there’s a disruption to our gut microbiome, problems can arise. Now, researchers are investigating how HIV and the microbiome are linked.

Published
25 February 2016
From
BETA blog
HIV-infected vaginal cells do not transmit HIV if plasma viral load is undetectable, researchers find

A group of researchers have cleared up an important question about HIV transmission, in experiments on mice. Although HIV-infected CD4 cells persist in the vagina even on

Published
15 February 2016
By
Gus Cairns
Two cases of PrEP failure on solo tenofovir pose significant research questions

A report originally presented to the 2015 BHIVA conference last year details two cases where therapeutic levels of solo tenofovir unequivocally failed to prevent HIV infection in

Published
14 January 2016
By
Gus Cairns
Does low-level HIV viral load raise the risk of disease progression and co-morbidities?

People living with HIV who have a detectable but low viral load – in the range of 50 to 500 or 1000 copies/ml – may continue to

Published
09 November 2015
By
Liz Highleyman
Fat Tissue May Be Another Part of HIV Reservoir

In addition to possibly being a component of the HIV reservoir, fat tissue may also be a source of harmful chronic inflammation among those living with the virus. Publishing their findings in PLOS Pathogens, researchers studied adipose (fat) tissue in both macaque monkeys infected with SIV, HIV’s simian cousin, as well as HIV-positive humans who underwent elective abdominal surgery.

Published
28 September 2015
From
Aidsmeds
Infection with multiple HIV-1 variants leads to poorer clinical outcomes

HIV-1 infection with multiple founder variants points to poorer clinical outcomes than infection with a single variant, according to a paper published today in Nature Medicine. In the study researchers analyzed large sample sets from two important HIV vaccine efficacy trials -- the Step HIV vaccine clinical trial (HVTN 502) and RV144, the landmark vaccine clinical trial conducted in Thailand -- to evaluate whether genetic characteristics of the founder viral populations could influence markers of clinical outcomes.

Published
01 September 2015
From
Eurekalert Inf Dis

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.